Skip to main content
. 2022 Mar 18;11(3):248–258. doi: 10.1093/stcltm/szab022

graphic file with name szab022f0003.jpg

Various immune cell types have been found to modulate the activity of endogenous stem/progenitor cells in animal models of tissue healing. These novel findings may be leveraged for developing better regenerative medicine strategies that integrate immune components. This review highlights mechanisms by which immune cells control endogenous stem/progenitor cells and present regenerative approaches that take advantage of this cross-talk.